J. Safra Sarasin Holding’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.59M Buy
117,689
+8,660
+8% +$470K 0.09% 149
2026
Q1
$6.84M Sell
109,029
-161,436
-60% -$12.9M 0.12% 122
2025
Q4
$25.8M Sell
270,465
-36,293
-12% -$3.56M 0.42% 68
2025
Q3
$29.9M Buy
306,758
+106,109
+53% +$11M 0.48% 63
2025
Q2
$21.6M Buy
200,649
+37,784
+23% +$3.82M 0.37% 77
2025
Q1
$16.4M Buy
162,865
+98,900
+155% +$9.96M 0.3% 87
2024
Q4
$5.71M Sell
63,965
-19,208
-23% -$1.69M 0.1% 131
2024
Q3
$6.97M Sell
83,173
-31,346
-27% -$2.47M 0.12% 120
2024
Q2
$8.82M Buy
+114,519
New +$8.38M 0.16% 112

Other funds holding BSX

J. Safra Sarasin Holding's BSX Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Boston Scientific (BSX) stake by 7.9% in Q2 2026, buying an estimated $470K and bringing the position to 117,689 shares worth $6.59M. The position accounts for 0.09% of the portfolio, ranked #149.

J. Safra Sarasin Holding first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.9M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • J. Safra Sarasin Holding held 117,689 shares of Boston Scientific worth $6.59M as of Q2 2026.
  • J. Safra Sarasin Holding bought 8,660 Boston Scientific shares in Q2 2026, an estimated $470K.
  • Boston Scientific made up 0.09% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #149 holding.
  • J. Safra Sarasin Holding first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's Boston Scientific position peaked at $29.9M in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.